Immune Checkpoint Inhibitors for Patients With Advanced Non-Small-Cell Lung Cancer: A Systematic Review.

Ellis, Peter M; Vella, Emily T; Ung, Yee C

Immune Checkpoint Inhibitors for Patients With Advanced Non-Small-Cell Lung Cancer: A Systematic Review.

Ellis, Peter M; Vella, Emily T; Ung, Yee C.

Affiliation

Ellis PM; Medical Oncology, Juravinski Cancer Centre, and Department of Oncology, McMaster University, Hamilton, Ontario, Canada.
Vella ET; Program in Evidence-Based Care, McMaster University, Hamilton, Ontario, Canada. Electronic address: ccopgi@mcmaster.ca.
Ung YC; Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada.

Clin Lung Cancer ; 18(5): 444-459.e1, 2017 09.

Article in En | MEDLINE | ID: mdl-28416123

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Antibodies, Monoclonal/therapeutic use; Antineoplastic Agents, Immunological/therapeutic use; B7-H1 Antigen/antagonists & inhibitors; Carcinoma, Non-Small-Cell Lung/drug therapy; Lung Neoplasms/drug therapy; Programmed Cell Death 1 Receptor/antagonists & inhibitors; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Non-Small-Cell Lung/secondary; Humans; Lung Neoplasms/pathology; Neoplasm Staging; Nivolumab; Randomized Controlled Trials as Topic; Survival Rate

Key words

Atezolizumab; Chemotherapy; Docetaxel; Nivolumab; Pembrolizumab

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Antibodies, Monoclonal, Humanized / B7-H1 Antigen / Programmed Cell Death 1 Receptor / Antineoplastic Agents, Immunological / Lung Neoplasms / Antibodies, Monoclonal Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2017 Type: Article Affiliation country: Canada

Fulltext

XML

PubMed Links

Search on Google